All eyes on the prefusion-stabilized F construct, but are we missing the potential of alternative targets for respiratory syncytial virus vaccine design?
Source
Vaccines - ISSN 2076-393X-12:1 (2024) p. 1-27
Subtractive immunization as a method to develop respiratory syncytial virus (RSV)—specific monoclonal antibodies
Source
Antibodies - ISSN 2073-4468-12:4 (2023) p. 1-12
The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains
Source
Science translational medicine - ISSN 1946-6234-15:710 (2023) p. 1-13
Risk factors associated with severe RSV infection in infants : what is the role of viral co-infections?
Source
Microbiology spectrum - ISSN 2165-0497-11:3 (2023) p. 1-11
Bronchiolitis in COVID-19 times : a nearly absent disease?
Source
European journal of pediatrics - ISSN 0340-6199-180 (2021) p. 1969-1973